3-[3-(5,5,8,8-Tetramethyl-5,6,7,8-tetrahydro-2-naphthylcarbonyl)phenyl]acrylic acid | 185685-39-6

• 分子结构分类: 有机化合物 - 苯类化合物 - 苯和取代衍生物
• 英文名称: 3-[3-(5,5,8,8-Tetramethyl-5,6,7,8-tetrahydro-2-naphthylcarbonyl)phenyl]acrylic acid
• 英文别名: (E)-3-[3-(5,5,8,8-tetramethyl-6,7-dihydronaphthalene-2-carbonyl)phenyl]prop-2-enoic acid
• CAS: 185685-39-6
• 化学式: C₂₄H₂₆O₃
• 分子量: 362.469
• InChiKey: KUGSQBMMMFDZHA-DHZHZOJOSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  6.3
• 重原子数：
  27
• 可旋转键数：
  4
• 环数：
  3.0
• sp3杂化的碳原子比例：
  0.33
• 拓扑面积：
  54.4
• 氢给体数：
  1
• 氢受体数：
  3

反应信息

• 作为反应物：
  描述：

  3-[3-(5,5,8,8-Tetramethyl-5,6,7,8-tetrahydro-2-naphthylcarbonyl)phenyl]acrylic acid 在 sodium tetrahydroborate 作用下， 以95%的产率得到(E)-3-[3-[hydroxy-(5,5,8,8-tetramethyl-6,7-dihydronaphthalen-2-yl)methyl]phenyl]prop-2-enoic acid
  参考文献：
  名称：

  Application of the Heck reaction in the synthesis of truncated naphthoic acid retinoids

  摘要：

  A series of truncated naphthoic acid retinoids have been prepared using the Heck reaction. These retinoids were evaluated in the RAR transactivation assay in vitro and in the utriculi reduction assay in vivo. It has been found that the naphthalene ring of the retinoids is crucial for their retinoid activity and receptor selectivity. Copyright (C) 1996 Elsevier Science Ltd

  DOI：

  10.1016/s0960-894x(96)00523-9
• 作为产物：
  描述：

  3-碘苯甲酰氯 在 palladium diacetate sodium hydroxide 、 三氯化铝 、 三正丁胺 、 (2-Tol)23P 作用下， 生成 3-[3-(5,5,8,8-Tetramethyl-5,6,7,8-tetrahydro-2-naphthylcarbonyl)phenyl]acrylic acid
  参考文献：
  名称：

  Application of the Heck reaction in the synthesis of truncated naphthoic acid retinoids

  摘要：

  A series of truncated naphthoic acid retinoids have been prepared using the Heck reaction. These retinoids were evaluated in the RAR transactivation assay in vitro and in the utriculi reduction assay in vivo. It has been found that the naphthalene ring of the retinoids is crucial for their retinoid activity and receptor selectivity. Copyright (C) 1996 Elsevier Science Ltd

  DOI：

  10.1016/s0960-894x(96)00523-9

文献信息

• 二芳香族化合物、それらを含む薬理学的および化粧品組成物、およびその用途
  申请人：——

  公开号：JP2001233821A

  公开（公告）日：2001-08-28

  (57)【要約】 （修正有）\n【課題】新規なヒト又は動物用医薬品（特に皮膚科学的、リウマチ性、呼吸器、心血管及び服科的病訴）の提供。\n【解決手段】一般式（Ｉ）\nを有する二芳香族化合物。代表例として下記化合物が挙げられる。３−［３−（５，５，８，８−テトラメチル−５，６，７，８−テトラヒドロ−２−ナフチルカルボニル）フェニル］アクリル酸。

  (57) [摘要]（有修改）Јn [问题]提供新型人类或兽类药物（特别是用于皮肤病、风湿病、呼吸系统、心血管和牙科疾病）。\解决方法】具有通式（I）的双芳香族化合物。代表性的例子包括以下化合物： 3-[3-(5,5,8,8-四甲基-5,6,7,8-四氢-2-萘羰基）苯基）丙烯酸。
• COMPOSES BIAROMATIQUES, COMPOSITIONS PHARMACEUTIQUES ET COSMETIQUES LES CONTENANT ET UTILISATIONS
  申请人：CENTRE INTERNATIONAL DE RECHERCHES DERMATOLOGIQUES GALDERMA - CIRD GALDERMA

  公开号：EP0915823A1

  公开（公告）日：1999-05-19
• Method for treating cachexia with retinoid ligands
  申请人：Jiang Guang Liang

  公开号：US20070185055A1

  公开（公告）日：2007-08-09

  The present invention relates to a method of treatment of cachexia in a subject in need of treatment. More specifically, the present invention relates to the use of retinoid compounds that act on retinoid X receptors (RXRs) for the treatment of cachexia in a subject in need of treatment. The cachexia is associated with, in other words a complication of, a primary disease, condition or disorder. Primary diseases, conditions and disorders include, but are not limited to, cancer, AIDS, liver cirrhosis, diabetes mellitus, chronic renal failure, chronic obstructive pulmonary disease, chronic cardiac failure, immune system diseases (e.g., rheumatoid arthritis and systemic lupus erythematosus), tuberculosis, cystic fibrosis, gastrointestinal disorders (e.g., irritable bowel syndrome and inflammatory bowel disease), Parkinson's disease, anorexia nervosa, dementia, major depression, an aged condition and sarcopenia.
• US6258775B1
  申请人：——

  公开号：US6258775B1

  公开（公告）日：2001-07-10
• [EN] BI-AROMATIC COMPOUNDS, PHARMACEUTICAL AND COSMETIC COMPOSITIONS CONTAINING SAME AND USES<br/>[FR] COMPOSES BIAROMATIQUES, COMPOSITIONS PHARMACEUTIQUES ET COSMETIQUES LES CONTENANT ET UTILISATIONS
  申请人：CENTRE INTERNATIONAL DE RECHERCHES DERMATOLOGIQUES GALDERMA (C.I.R.D. GALDERMA)

  公开号：WO1998022423A1

  公开（公告）日：1998-05-28

  (EN) The invention concerns novel bi-aromatic compounds of general formula (I): (I) and their use in pharmaceutical compositions for use as human or veterinary medicine (in particular for treating dermatological, rheumatic, respiratory, cardiovascular and ophthalmologic disorders), or for use in cosmetic compositions.(FR) L'invention concerne de nouveaux composés biaromatiques qui présentent comme formule générale (I) ainsi que l'utilisation de ces derniers dans des compositions pharmaceutiques destinées à un usage en médecine humaine ou vétérinaire (affections dermatologiques, rhumatismales, respiratoires, cardiovasculaires et ophtalmologiques notamment), ou bien encore dans des compositions cosmétiques.